Cytokinetics Inc (NASDAQ:CYTK)
| 25.51 Delayed Data As of Jul 10 |  -0.61 / -2.34%Today’s Change | 7.73 Today|||52-Week Range 28.25 | +140.43% Year-to-Date |
Latest CYTK News | Press Releases
No recent news for Cytokinetics Inc.
Today’s Trading
| Previous close | 26.12 |
| Today’s open | 27.50 |
| Day’s range | 25.27 - 28.24 |
| Volume | 49,660 |
| Average volume (3 months) | 871,442 |
| Market cap | $1.5B |
Data as of 3:59pm ET, 07/10/2020
Growth & Valuation
| Earnings growth (last year) | -8.22% |
| Earnings growth (this year) | -5.69% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -14.71% |
| P/E ratio | NM |
| Price/Sales | 22.74 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ZGNXZogenix Inc | -0.58 | -2.09% |
| IRWDIronwood Pharmaceuti... | -0.01 | -0.10% |
| ---- | ||
| ZYMEZymeworks Inc | -1.90 | -5.41% |
Data as of 4:00pm ET, 07/10/2020
Financials
| Next reporting date | July 29, 2020 |
| EPS forecast (this quarter) | -$0.56 |
| Annual revenue (last year) | $26.9M |
| Annual profit (last year) | -$121.7M |
| Net profit margin | -452.93% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
